![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Feedback Plc | LSE:FDBK | London | Ordinary Share | GB00BJN59X09 | ORD 50P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 60.50 | 60.00 | 61.00 | 60.50 | 60.50 | 60.50 | 14,770 | 07:44:37 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Electronic Computers | 1.03M | -2.92M | -0.2188 | -2.77 | 8.07M |
Date | Subject | Author | Discuss |
---|---|---|---|
04/5/2020 14:24 | Mms seem to be taking full advantage today! | ![]() ducatiman | |
04/5/2020 13:58 | Yes Yump, the closest I know anyone dealing with the NHS, is a cousin has an haulage business that is shipping PPE almost 7 days a week into them; he tells me their procurement is really disorganised (why he can hardly stop work as an aside). Even a lay person such as me can see the benefits of Bleepa, what I can’t fathom is the profit potential but I’m a shortish term trader and long term investor here. If I can keep getting my average down, I’ll be happy to see it play out and pick up on you longer term holders knowledge :) | ![]() riggerbeautz | |
04/5/2020 11:57 | Riggerbeautz Exactly why I'm here. Lost on medical stocks before so very wary. FDBK have a similarly dire track record to some of my worst stocks in the past. Its just the simplicity of Bleepa and the potential for widespread adoption that made me invest a bit. It remains to be seen whether simplicity is relevant to getting adoption in the NHS, or whether it will meet with the same 'complications' that every product seems to have, of budgets, different opinions, clinicians almost being their own bosses (so behaving 'independently'. I don't want to count the number of times I've seen NICE, the NHS and whoever else spouting the phrases about 'adopting new tech at pace and scale' !! Its been a great example of 'just saying something a lot won't make it happen'. | ![]() yump | |
04/5/2020 11:51 | Boredom setting in probably. There'll still be loads of traders in here - that volume recently wouldn't have been longer termers - they don't generally pile in suddenly. | ![]() yump | |
04/5/2020 11:17 | Might be something to do with IQAI results and postponement of stonechecker sale ... noting that stonechecker requires ongoing license from feedback to operate texrad. If that's what it is I think should just be ignored as the ultimate value here should be via Bleepa if successfully rolled out beyond pennine. | ![]() meganxmas | |
04/5/2020 11:04 | Why the drop? MMs playing their games again? | sonie01 | |
04/5/2020 10:58 | You're welcome! | ![]() ged5 | |
04/5/2020 10:48 | Thank you Ged, from the sense of the thread I think a fair few are like myself. I’m in as I said, just not convinced to go much more; particularly as anything healthcare I normally steer well clear of and know little about but the covid bingo is in vogue and of all the products, the concept of remote working technology seems very compelling and is pretty simple to get! Even for a non pharma/health sector investor like me! | ![]() riggerbeautz | |
04/5/2020 10:14 | The way in which clinicians are accessing clinical information is changing. Clinicians want to be able to access information on the go, from their own devices, rather than being chained to ward based computer terminals which are themselves potential sources of contamination and infection. In this communication revolution clinicians already have the hardware they need at home. Enabling clinicians to work in the way they want to, through technology, will transform not only the NHS response to Covid-19 but also transform clinical practice into the future. Providing this flexibility securely will dramatically improve the speed and accuracy of clinical decision making by connecting clinicians – allowing them to have access to other specialists who may be in isolation. | ![]() ged5 | |
04/5/2020 09:40 | Good morning Riggerbeautz, Thread started just after I bought in. Like you I read through the previous thread. I bought because: they'd just had a placing I liked that the placing was for FDA approval of TexRAD Alastair Riddell was very convincing in his interview big names: GE healthcare, Siemens, Alliance Medical and Samsung were mentioned in previous announcements. Balaji Ganeshan, the co-founder of TexRAD was on the board. Nothing seemed to develop. Then Tom Oakley was appointed. He seemed like a breath of fresh air. His focus was on Cadran the lesser known but more lucrative product. (120K compared to TexRAD's 50K) Mike Hayball and Future Processing were working on Cadran developments. Tom Oakley, young, energetic, medical background and entrepreneur became the voice of Feedback. He communicated. Big names are being mentioned in interviews. Microsoft and Amazon. Will he deliver? At first I believed he would. At the moment he's not replying to emails but to be fair the last announcement was only 2 weeks ago and he has done interviews and the LiveStream chat. Does he convince me? He would if he answered questions about Papworth and Fluoroscopy. Is Bleepa in one hospital or four? Sometimes I think his interviews are addressed to the NHS community not shareholders. He believes in Bleepa. From one email, I believe him to be passionate about Bleepa. Bleepa has tremendous potential. I calculated a reasonable share price of 8p earlier on this thread. But sometimes I think he withholds information and I wonder who is guiding him with respect to answering shareholders. I'm sure I've said before that the jury is still out. | ![]() ged5 | |
03/5/2020 16:19 | Rigger, many of us lils can’t make up our minds about him either! | ![]() ducatiman | |
03/5/2020 16:13 | Reading back this thread it seems the CE Mark has been discussed since late last year. Found it interesting to see so many are long term holders that have been in since the thread started and no doubt before, with only a few of you such as gymratt have sold out on spikes, but without fully understanding the technology. So let me ask as like a lot of previous comments posted in more doubting times, I can’t make my mind up about Tom Oakley, what makes people think he will deliver? The YouTube videos don’t entirely convince me. | ![]() riggerbeautz | |
03/5/2020 11:54 | Nobody knows how long it will take and the EU database for medical devices is not available to the public until at least 2022 so anyone can guess for now. Suggest everybody stops fretting about it. I know we get a CE mark to put on the product at the end of it all but China puts the very same mark, same font, everything, identical in all respects on all of its medical products and passes them off as CE certified when their CE mark only means Chinese Export. As long as Bleepa works and the NHS want it, that should do. The UK is out of the moribund EU, the CE mark is not required until Bleepa is sold into Europe. Waste of time worrying about it. Bloody isolation must be getting to me. I'd have ignored all this CE mark talk a month or so ago. | ![]() lr2 | |
03/5/2020 11:24 | Has anyone noticed that we’ve got covid going on ? For all we know ‘imminent̵ If you want to see how long ‘imminent̵ Bearing in mind how many times you’ve ever heard anyone say ‘I don’t know’. On ADVFN, from a business or in politics, or anywhere. | ![]() yump | |
03/5/2020 11:21 | Has anyone noticed that we’ve got covid going on ? For all we know ‘imminent̵ If you want to see how long ‘imminent̵ | ![]() yump | |
03/5/2020 10:47 | Zoos, I am beginning to wonder about this CE Mark. If as Ged suggests Bleepa is now in four hospitals, does that mean that we have the CE Mark but they haven’t announced it or does it mean that it is not required to enable Bleepa to be rolled out? TO said it was required as Bleepa was a medical device and did say 4 weeks ago that it was imminent. We really need an update to clarify the situation. Maybe next week. | ![]() ducatiman | |
03/5/2020 10:27 | Exactly where’s the ‘imminent̵ | ![]() zooskeeper | |
03/5/2020 09:32 | No Tom. We want genuine news not a retweet of old news. Did you really miss a trick by not emphasising moving Bleepa to one hospital to four hospitals? | ![]() ged5 | |
03/5/2020 09:04 | Just like it was primed in August 2019 then plummeted. Is that what you mean? | texaschaser | |
02/5/2020 13:54 | Ged, the chart is nicely primed! SSB? | ![]() ducatiman | |
02/5/2020 13:53 | I wonder how many people will get a call from work on Monday asking if they are ok? I was all set for Monday off untill I became aware of the change last Tuesday. | ![]() ducatiman | |
02/5/2020 11:24 | Thanks for the correction last night LR2. It got me looking at the RNS again. For some reason, laziness, dementia or just not concentrating, I misread the RNS, yet again. I got it in my head Bleepa was being rolled out across the Royal Oldham hospital having been in just one department. But the RNS clearly states "that Bleepa ® , Feedback's flagship imaging-based communication platform, will be rolled-out across the Pennine Acute Hospitals NHS Trust with immediate effect as a key patient management tool to assist its coronavirus response." So it would be reasonable to think Bleepa is now in FOUR hospitals. Checking whether The Royal Oldham hospital was a GDE fast follower site (it wasn't on one of the NHS sites) I came across this from February 2019: The link also explains the link between Salford Royal Trust and Pennine Acute Hospitals Trust. | ![]() ged5 | |
02/5/2020 11:09 | thanks my mistake fanny | ![]() fanramptastic mate | |
02/5/2020 10:57 | Bank holiday has been moved back to Friday 8th May to coincide with VE day 75th anniversary. | ![]() digger2779 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions